EUVIMEDEUVIMED entdecken
Crossref

Isoprenylation is Critical for IL-33-mediated Mast Cell Inflammatory Function and Allergic Disease

Destiny T. Pryor

VCU Scholars Compass (Virginia Commonwealth University) · 01.01.2024

DOI: 10.25772/gye0-5b91 ↗

Kurz gefasst

Fachartikel in der Zeitschrift VCU Scholars Compass (Virginia Commonwealth University), erschienen am 01.01.2024. Verfasst von Destiny T. Pryor.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Allergic asthma is an inflammatory disease of the airway associated with sensitization to allergens and symptoms such as sneezing, wheezing, and airway hyperresponsiveness. The severity of this disease varies between sex, age, and race; therefore, understanding the signaling mechanisms driving allergic asthma is integral to developing targeted therapeutics. Mast cells (MC), an important effector cell in allergic disease, can be activated by interleukin (IL)-33, an alarmin released after cells have contact with cellular stressors including common allergens. In response to IL-33, MCs release inflammatory cytokines and lipid mediators. We previously found that statins suppress IgE-mediated MC activation by inhibiting protein isoprenylation. Therefore, we hypothesized that directly targeting the isoprenylation enzymes farnesyl transferase (FT) and geranylgeranyl transferase (GGT) would suppress IL-33-mediated MC function. We show that the dual transferase inhibitor FGTI-2734 decreased IL-33-mediated inflammatory cytokine secretion, effects that were mimicked by simvastatin. In contrast to the dual inhibitor, suppressing only FT or GGT had no effect on cytokine secretion. These data suggest that inhibiting farnesyl and geranylgeranyl transferases is a potential treatment for IL-33-mediated mast cell activation and allergic disease.

Schlagwörter

isoprenylationIL-33mast cellsallergic asthmafarnesyltransferasegeranylgeranyltransferasesimvastatininflammatory cytokine secretionalarminsIgE-mediated mast cell activation

Zitieren

APA

Pryor, D. T. (2024). Isoprenylation is Critical for IL-33-mediated Mast Cell Inflammatory Function and Allergic Disease. VCU Scholars Compass (Virginia Commonwealth University). https://doi.org/10.25772/gye0-5b91

Vancouver

Pryor DT. Isoprenylation is Critical for IL-33-mediated Mast Cell Inflammatory Function and Allergic Disease. VCU Scholars Compass (Virginia Commonwealth University). 2024. doi:10.25772/gye0-5b91

BibTeX
@article{Pryor2024,
  author = {Pryor, Destiny T.},
  title = {Isoprenylation is Critical for IL-33-mediated Mast Cell Inflammatory Function and Allergic Disease},
  journal = {VCU Scholars Compass (Virginia Commonwealth University)},
  year = {2024},
  doi = {10.25772/gye0-5b91}
}
Kostenlos starten →